✦ LIBER ✦

PCN86 DRUG UTILIZATION AND COST CONSIDERATIONS OF ERYTHROPOIESIS-STIMULATING AGENTS (ESAS) IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)

✍ Scribed by F Laliberte; RS Mckenzie; P Lefebvre; B Bookhart; F Vekeman; M Duh; CT Piech

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN32 RECENT ERYTHROPOIESIS STIMULATING

✍ FK Kokkotos; RA Bailey; M Kerr; S Shen; M Senbetta; RS McKenzie 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

PCN25 DRUG UTILIZATION AND COSTS FOR ERY

✍ MH Lafeuille; RS McKenzie; F Vekeman; R Bailey; CT Piech; P Lefebvre 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

PCN89 DRUG UTILIZATION PATTERNS AND COST

✍ A Gosselin; MH Lafeuille; B Bookhart; P Lefebvre; RS Mckenzie; F Vekeman; CT Pie 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

41: Recent Erythropoiesis Stimulating Ag

✍ Robert A. Bailey; Fotios Kokkotos; Matthew Kerr; Sherlynn Shen; Mekre Senbetta; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 96 KB

147: Drug Utilization and Cost Considera

✍ Samir Mody; Francis Vekeman; Antoine Gosselin; Brahim Bookhart; R. Scott McKenzi 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 191 KB

140: Assessment of Drug Utilization Patt

✍ Patrick Lefebvre; François Laliberté; Marie-Héléne Lafeuille; Brahim Bookhart; R 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 196 KB